Supriya Lifescience Ltd (SPRL)

Currency in INR
683.35
-7.35(-1.06%)
Closed·
SPRL Scorecard
Full Analysis
Has a perfect Piotroski Score of 9
Earnings results expected in 13 days
Fair Value
Day's Range
681.60696.80
52 wk Range
376.15841.70
Key Statistics
Bid/Ask
683.35 / 683.35
Prev. Close
690.7
Open
690.3
Day's Range
681.6-696.8
52 wk Range
376.15-841.7
Volume
14.14K
Average Volume (3m)
17.84K
1-Year Change
78.84%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SPRL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Supriya Lifescience Ltd Company Profile

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, the company is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessasion, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic, stem cell transplantation, and anti-migraine. The company was founded in 1987 and is headquartered in Mumbai, India.

Employees
448
Market
India

Compare SPRL to Peers and Sector

Metrics to compare
SPRL
Peers
Sector
Relationship
P/E Ratio
29.3x31.2x−0.5x
PEG Ratio
0.510.800.00
Price/Book
5.5x3.6x2.6x
Price / LTM Sales
7.9x3.6x3.2x
Upside (Analyst Target)
23.4%7.2%41.7%
Fair Value Upside
Unlock−4.1%6.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 23.35%
Dividend Yield
0.12%
Industry Median 0.74%
Annualised payout
0.80
Paid annually
5-Years Growth
-12.94%
Growth Streak

Earnings

Latest Release
May 27, 2025
EPS / Forecast
6.29 / --
Revenue / Forecast
1.92B / --
EPS Revisions
Last 90 days

SPRL Income Statement

People Also Watch

468.55
TDPS
-2.41%
10.33
EASM
-0.86%
1,688.80
COFO
+0.76%
7,468.50
APLH
+1.43%
992.80
GABR
+0.08%

FAQ

What Stock Exchange Does Supriya Lifescience Ltd Trade On?

Supriya Lifescience Ltd is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Supriya Lifescience Ltd?

The stock symbol for Supriya Lifescience Ltd is "SPRL."

What Is the Supriya Lifescience Ltd Market Cap?

As of today, Supriya Lifescience Ltd market cap is 55.04B.

What Is Supriya Lifescience Ltd's Earnings Per Share (TTM)?

The Supriya Lifescience Ltd EPS (TTM) is 23.35.

When Is the Next Supriya Lifescience Ltd Earnings Date?

Supriya Lifescience Ltd will release its next earnings report on 07 Aug 2025.

From a Technical Analysis Perspective, Is SPRL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Supriya Lifescience Ltd Stock Split?

Supriya Lifescience Ltd has split 0 times.

How Many Employees Does Supriya Lifescience Ltd Have?

Supriya Lifescience Ltd has 448 employees.

What is the current trading status of Supriya Lifescience Ltd (SPRL)?

As of 26 Jul 2025, Supriya Lifescience Ltd (SPRL) is trading at a price of 683.35, with a previous close of 690.70. The stock has fluctuated within a day range of 681.60 to 696.80, while its 52-week range spans from 376.15 to 841.70.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.